HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of post-traumatic acute renal failure with peritoneal dialysis.

Abstract
To evaluate the efficacy of peritoneal dialysis (PD) in the management of post-traumatic renal failure, the authors reviewed the courses of five critically injured patients treated with PD over an 18-month period. Each patient had a double-cuffed PD catheter inserted through a subcutaneous tunnel with PD initiated within 48 hours. The dialysis prescription was individualized for each patient with frequent exchanges performed using either a manual manifold system or a continuous cycling machine. Three of the five patients survived and none of the survivors required dialytic therapy at discharge. Duration of PD ranged from 10 to 57 days. Three patients required intermittent hemodialysis (HD) due to progressive azotemia and hyperkalemia. Two patients developed bacterial peritonitis and three patients developed hyperglycemia with PD continuing without interruption in each patient. When compared to HD, PD offers the advantages of better hemodynamic tolerance, no anticoagulation, no vascular access, and a reduced personnel requirement if continuous cyclic PD is used.
AuthorsT R Howdieshell, W E Blalock, P A Bowen, M L Hawkins, C Hess
JournalThe American surgeon (Am Surg) Vol. 58 Issue 6 Pg. 378-82 (Jun 1992) ISSN: 0003-1348 [Print] United States
PMID1596040 (Publication Type: Journal Article)
Chemical References
  • Creatinine
Topics
  • Academic Medical Centers
  • Acute Kidney Injury (blood, etiology, therapy)
  • Adult
  • Aged
  • Blood Urea Nitrogen
  • Creatinine (blood)
  • Evaluation Studies as Topic
  • Georgia (epidemiology)
  • Humans
  • Male
  • Middle Aged
  • Multiple Trauma (complications, etiology, mortality)
  • Peritoneal Dialysis (instrumentation, methods, standards)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: